Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells
about
Chimeric receptors of the human C3a receptor and C5a receptor (CD88)Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activityIn Xenopus oocytes the human C3a and C5a receptors elicit a promiscuous response to the anaphylatoxinsChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strainsThe human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytesDetection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skinReceptor for the C3a anaphylatoxin is expressed by neurons and glial cellsComplement System Part II: Role in ImmunityIdentification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast.Genomic organization of the human C3a receptor.Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin.A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.Complementing the inflammasome.The role of the anaphylatoxins in health and disease.Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.In vitro allergen challenge of peripheral blood induces differential gene expression in mononuclear cells of asthmatic patients: inhibition of cytosolic phospholipase A2alpha overcomes the asthma-associated response.Complement pathway amplifies caspase-11-dependent cell death and endotoxin-induced sepsis severity.Overview of complement activation and regulationThe transcription factors AP-1 and Ets are regulators of C3a receptor expression.Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance.Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.Ligand-induced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by "G protein-coupled receptor kinases.Role of the second extracellular loop of human C3a receptor in agonist binding and receptor function.Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB.The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg).Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3aThe C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation.Contribution of anaphylatoxins to allergic inflammation in human lungs.Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse.Complement component anaphylatoxins upregulate chemokine expression by human astrocytes.Ablation of the complement C3a anaphylatoxin receptor causes enhanced killing of Pseudomonas aeruginosa in a mouse model of pneumonia.
P2860
Q22009065-33895B4D-C512-4677-A95B-E5BA7363410CQ22010463-9F39A28C-0E40-42B2-8AB7-B740038D8FC6Q24317538-A2A2D679-EEB8-4E47-A6D2-8C3C9A10083FQ24319950-BD52147F-C77B-490F-9754-3D4A96AAFE72Q24653022-F8D2B5F3-BEC9-4C71-8736-E6D92F00F85EQ24682489-8926A19A-97C1-4376-B671-03A2034CEDF5Q28144535-C7CEE00C-AB5C-4568-912B-6316C86F1F0FQ28263460-39C8A0A5-4183-49B6-BA7E-AA844990FBA3Q31954184-F0FD64C7-B666-4098-98DE-6716BCB526D5Q32037081-80AA4A9F-1FC4-4AA6-90F1-058BA31EE192Q34215630-F835F434-84BF-4C38-A8C1-91868B91961DQ34494082-A92366F0-2870-4242-8B9C-7B7F5CFCC2A8Q34501875-3624D87C-65D4-46EA-9C98-9CBD3681227AQ34983578-36FADD27-D23D-434C-BF9B-96CD52A8641BQ36913772-738B7718-B4F4-4DA5-905F-3AE3E17DF07AQ37035482-224ED79E-AAE8-4137-8C1A-7D946CDD905FQ37346659-BF97B140-39D4-48F1-B506-75381D0BB97AQ38155650-B06135A1-9779-4AA1-8E8B-61785A14B7DCQ38319410-B56FF466-5984-49F0-A1BA-189AAB2E53BCQ38756155-74ED2BDA-A562-402E-9C2F-200879E847B2Q40140325-D49AEB17-CBCD-47FD-BF88-6FF5CE324567Q40912578-E193F119-5C76-4173-92D8-42D45F44E05BQ40925447-03C7A0A1-15BE-4077-B6A0-F12A2A0F5B19Q40964892-79A7DAB9-320C-4011-B8F6-1D4F90BC04B1Q41003668-860BE4B7-9F97-4A77-8B5E-E30631854C11Q41064968-5658A124-D139-475A-85B0-D2ACA3305D69Q41516139-E4F2F6AE-D1BE-44EE-A54D-7C883917BDA8Q42796229-D7D25D80-DD2A-4502-8449-4B076BE75CB3Q46815105-2EB2426C-8AC7-445C-B70A-C8A8930D63D6Q48261622-F0230C21-5547-487E-829D-753607DB11D4Q48379517-4D9B61E3-7DF5-487E-956B-520B46D5D997Q53637737-673B79B2-E1A1-4334-B02E-3E7E5D5213C1
P2860
Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Expression cloning of the huma ...... rom differentiated U-937 cells
@ast
Expression cloning of the huma ...... rom differentiated U-937 cells
@en
Expression cloning of the huma ...... rom differentiated U-937 cells
@en-gb
Expression cloning of the huma ...... rom differentiated U-937 cells
@nl
type
label
Expression cloning of the huma ...... rom differentiated U-937 cells
@ast
Expression cloning of the huma ...... rom differentiated U-937 cells
@en
Expression cloning of the huma ...... rom differentiated U-937 cells
@en-gb
Expression cloning of the huma ...... rom differentiated U-937 cells
@nl
prefLabel
Expression cloning of the huma ...... rom differentiated U-937 cells
@ast
Expression cloning of the huma ...... rom differentiated U-937 cells
@en
Expression cloning of the huma ...... rom differentiated U-937 cells
@en-gb
Expression cloning of the huma ...... rom differentiated U-937 cells
@nl
P2093
P3181
P356
P1476
Expression cloning of the huma ...... rom differentiated U-937 cells
@en
P2093
U Raffetseder
P304
P3181
P356
10.1002/EJI.1830260840
P407
P577
1996-08-01T00:00:00Z